Related references
Note: Only part of the references are listed.Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain
Netanel A. Horowitz et al.
BLOOD (2011)
Lysophosphatidic acid stimulates thrombomodulin lectin-like domain shedding in human endothelial cells
Hua-Lin Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response
Chung-Sheng Shi et al.
BLOOD (2008)
Involvement of α2-fucosyltransferase I (FUT1) and surface-expressed Lewisy (CD174) in first endothelial cell-cell contacts during angiogenesis
Thomas M. Moehler et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
DC-SIGN mediates adhesion and rolling of dendritic cells on primary human umbilical vein endothelial cells through LewisY antigen expressed on ICAM-2
Juan J. Garcia-Vallejo et al.
MOLECULAR IMMUNOLOGY (2008)
The role of Thrombomodulin in malignancy
Ann M. Hanly et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
The mouse cornea micropocket angiogenesis assay
Michael S. Rogers et al.
NATURE PROTOCOLS (2007)
Inhibition of xenograft tumor growth and down-regulation of ErbB receptors by an antibody directed against Lewis Y antigen
Hesso Farhan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Increasing post-event plasma thrombomodulin level associates with worse outcome in survival of acute coronary syndrome
Shih-Hung Chan et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis
M. Van de Wouwer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism
K Abeyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Evidence of human thrombomodulin domain as a novel angiogenic factor
CS Shi et al.
CIRCULATION (2005)
Antibodies directed against Lewis-Y antigen inhibit signaling of Lewis-Y modified ErbB receptors
M Klinger et al.
CANCER RESEARCH (2004)
The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value
S Iino et al.
CLINICAL CANCER RESEARCH (2004)
Thrombomodulin-mediated cell adhesion - Involvement of its lectin-like domain
HC Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor κB and mitogen-activated protein kinase pathways
EM Conway et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Separation and characterization of the molecular species of thrombomodulin in the plasma of diabetic patients
S Uehara et al.
THROMBOSIS RESEARCH (2001)
Increased levels of plasma thrombomodulin in patients with acute myocardial infarction who had thrombolytic therapy and achieved successful reperfusion
M Ileri et al.
CLINICAL CARDIOLOGY (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin
Y Hosaka et al.
CANCER LETTERS (2000)
Ley/H:: An endothelial-selective, cytokine-inducible, angiogenic mediator
MM Halloran et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
